The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support

The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management...

Descripción completa

Detalles Bibliográficos
Autores principales: Berardi, Cecilia, Bravo, Claudio A., Li, Song, Khorsandi, Maziar, Keenan, Jeffrey E., Auld, Jonathan, Rockom, Sunny, Beckman, Jennifer A., Mahr, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000165/
https://www.ncbi.nlm.nih.gov/pubmed/35407630
http://dx.doi.org/10.3390/jcm11072022
Descripción
Sumario:The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management of these patients. In this review, we discuss the history of LVADs, evaluating survival and complications over time. We also aim to discuss practical aspects of the medical and surgical management of LVAD patients and future directions for outcome improvement in this population.

Ejemplares similares